Bio-Rad Laboratories Inc (BIO)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,569,300 | 7,487,860 | 6,778,790 | 9,051,130 | 8,741,130 | 8,416,200 | 8,446,890 | 9,763,720 | 9,615,250 | 8,453,600 | 8,922,600 | 10,182,900 | 13,667,100 | 15,332,400 | 11,594,900 | 10,609,100 | 9,879,940 | 8,825,140 | 7,353,400 | 6,293,080 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $6,569,300K)
= 0.00
The debt-to-capital ratio for Bio-Rad Laboratories Inc has consistently been 0.00 for the past few years, indicating that the company has been funding its operations and growth primarily through equity rather than debt. A low or zero debt-to-capital ratio suggests that the company has a relatively lower financial risk and may have a strong financial position with a stable capital structure. However, it's important to note that while a low debt-to-capital ratio can be favorable, it also means the company may not be taking advantage of potential leveraging opportunities that could enhance returns for shareholders.
Peer comparison
Dec 31, 2024